XML 17 R7.htm IDEA: XBRL DOCUMENT v3.23.1
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY - USD ($)
shares in Thousands, $ in Thousands
Total
Common Stock
Additional Paid-in Capital
Treasury Stock
Accumulated Other Comprehensive Loss
Retained Earnings
Beginning balance (in shares) at Jun. 27, 2021   142,501        
Beginning balance at Jun. 27, 2021 $ 6,027,188 $ 143 $ 7,052,962 $ (15,646,701) $ (64,128) $ 14,684,912
Increase (Decrease) in Stockholders' Equity            
Issuance of common stock (in shares)   763        
Issuance of common stock 4,685 $ 1 4,684      
Purchase of treasury stock (in shares)   (4,654)        
Purchase of treasury stock (2,974,193) $ (5)   (2,974,188)    
Reissuance of treasury stock (in shares)   97        
Reissuance of treasury stock 46,380   42,271 4,109    
Equity-based compensation expense 189,476   189,476      
Net income 3,396,352         3,396,352
Other comprehensive income (loss) (33,538)       (33,538)  
Cash dividends declared (629,860)         (629,860)
Ending balance (in shares) at Mar. 27, 2022   138,707        
Ending balance at Mar. 27, 2022 6,026,490 $ 139 7,289,393 (18,616,780) (97,666) 17,451,404
Beginning balance (in shares) at Dec. 26, 2021   140,275        
Beginning balance at Dec. 26, 2021 6,475,781 $ 140 7,220,359 (17,294,255) (88,146) 16,637,683
Increase (Decrease) in Stockholders' Equity            
Issuance of common stock (in shares)   664        
Issuance of common stock 492 $ 1 491      
Purchase of treasury stock (in shares)   (2,232)        
Purchase of treasury stock (1,322,527) $ (2)   (1,322,525)    
Equity-based compensation expense 68,543   68,543      
Net income 1,021,778         1,021,778
Other comprehensive income (loss) (9,520)       (9,520)  
Cash dividends declared (208,057)         (208,057)
Ending balance (in shares) at Mar. 27, 2022   138,707        
Ending balance at Mar. 27, 2022 $ 6,026,490 $ 139 7,289,393 (18,616,780) (97,666) 17,451,404
Beginning balance (in shares) at Jun. 26, 2022 136,975 136,975        
Beginning balance at Jun. 26, 2022 $ 6,278,366 [1] $ 137 7,414,916 (19,481,429) (109,982) 18,454,724
Increase (Decrease) in Stockholders' Equity            
Issuance of common stock (in shares)   570        
Issuance of common stock 7,673 $ 1 7,672      
Purchase of treasury stock (in shares)   (2,984)        
Purchase of treasury stock (1,152,033) $ (3)   (1,152,030)    
Reissuance of treasury stock (in shares)   131        
Reissuance of treasury stock 44,996   39,366 5,630    
Equity-based compensation expense 218,105   218,105      
Net income 3,708,394         3,708,394
Other comprehensive income (loss) 4,887       4,887  
Cash dividends declared $ (703,000)         (703,000)
Ending balance (in shares) at Mar. 26, 2023 134,692 134,692        
Ending balance at Mar. 26, 2023 $ 8,407,388 $ 135 7,680,059 (20,627,829) (105,095) 21,460,118
Beginning balance (in shares) at Dec. 25, 2022   135,403        
Beginning balance at Dec. 25, 2022 8,304,635 $ 135 7,606,149 (20,071,931) (108,871) 20,879,153
Increase (Decrease) in Stockholders' Equity            
Issuance of common stock (in shares)   454        
Issuance of common stock 0 $ 1 (1)      
Purchase of treasury stock (in shares)   (1,165)        
Purchase of treasury stock (555,899) $ (1)   (555,898)    
Equity-based compensation expense 73,911   73,911      
Net income 814,008         814,008
Other comprehensive income (loss) 3,776       3,776  
Cash dividends declared $ (233,043)         (233,043)
Ending balance (in shares) at Mar. 26, 2023 134,692 134,692        
Ending balance at Mar. 26, 2023 $ 8,407,388 $ 135 $ 7,680,059 $ (20,627,829) $ (105,095) $ 21,460,118
[1] Derived from audited financial statements